Spirit AeroSystems Holdings, Inc. (SPR) Equity Alert: Contact Robbins LLP for Information about the Class Action Against Spirit AeroSystems Holdings, Inc. and the Deadline for Lead Plaintiff
May 24, 2023 11:58 ET
|
Robbins LLP
SAN DIEGO, May 24, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Spirit...
Wheels Up Experience Inc. (UP) Equity Alert: Stockholders Should Contact Robbins LLP for Information About Their Rights in Connection with the Class Action Against Wheels Up Experience Inc.
May 02, 2023 21:37 ET
|
Robbins LLP
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Wheels...
BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California
April 25, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 20, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article
March 29, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Promise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article
March 22, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
CORRECTION -- BetterLife Closes $1,857,143 of Private Placement
March 14, 2023 13:21 ET
|
BetterLife Pharma Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 14, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the...
BetterLife Closes $1,857,143 of Private Placement
March 14, 2023 10:00 ET
|
BetterLife Pharma Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 14, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the...
BetterLife Files Amended and Restated Offering Document for Offering of Units
March 10, 2023 19:10 ET
|
BetterLife Pharma Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the...
Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”
March 09, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, March 09, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...